The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
3 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $2,144,802 in first-year total cost, median $665,919.
Most frequent study sections
- Population and Public Health Approaches to HIV/AIDS Study Section[PPAH]3
Most frequent institutions
- NEW YORK UNIVERSITY SCHOOL OF MEDICINE2
- JOHNS HOPKINS UNIVERSITY1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2020 | Hybrid trial for Alcohol reduction among people with TB and HIV in India (HATHI)1R01AA027974-01 | CHANDER, GEETANJALIGUPTA, AMITA | JOHNS HOPKINS UNIVERSITY, MD | $665,919 | PPAH |
| 2019 | Could long-acting medications facilitate “ending AIDS by 2030” in southern Africa? An allocative efficiency analysis1R01AA027481-01A1 | BRAITHWAITE, RONALD SCOTT | NEW YORK UNIVERSITY SCHOOL OF MEDICINE, NY | $813,628 | PPAH |
| 2019 | From 90-90-90 to 95-95-95 and beyond: Optimizing and targeting combination HIV prevention for Zimbabwe and Kwazulu Natal1R01AA027976-01 | BRAITHWAITE, RONALD SCOTT | NEW YORK UNIVERSITY SCHOOL OF MEDICINE, NY | $665,255 | PPAH |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.